Table 4.
Treg subset panel of the patients.
| Parameters | All (n = 40) | Mild (n = 27) | Severe (n = 13) | P |
|---|---|---|---|---|
| CD4+CD25+ T cells, median ± IQR (%) | 16.43 ± 11.43 | 17.54 ± 15.93 | 15.68 ± 8.84 | 0.3166# |
| CD4+CD25+ T cells, median ± IQR (/μL) | 40.09 ± 56.26 | 40.48 ± 97.95 | 32.56 ± 34.53 | 0.0386# |
| Total Treg, mean ± SD (%) | 18.73 ± 1.31 | 15.26 ± 0.97 | 25.94 ± 2.56 | <0.0001 |
| Total Treg, median ± IQR (/μL) | 7.25 ± 11.82 | 7.21 ± 12.37 | 7.73 ± 8.27 | 0.4933# |
| Helios+ Treg, mean ± SD (%) | 53.77 ± 4.51 | 65.09 ± 4.43 | 30.25 ± 6.86 | <0.0001 |
| Helios+ Treg, median ± IQR (/μL) | 3.51 ± 9.38 | 4.74 ± 9.93 | 1.07 ± 3.16 | 0.0127# |
| Helios− Treg, mean ± SD (%) | 45.22 ± 4.53 | 33.57 ± 4.47 | 69.42 ± 6.58 | <0.0001 |
| Helios− Treg, median ± IQR (/μL) | 2.78 ± 4.48 | 2.18 ± 2.64 | 4.73 ± 4.54 | 0.0308# |
| CD39+ Treg, mean ± SD (%) | 32.01 ± 3.26 | 26.74 ± 3.58 | 42.95 ± 5.81 | 0.0177 |
| CD39+ T cell, median ± IQR (/μL) | 1.68 ± 3.88 | 1.32 ± 3.20 | 1.79 ± 3.81 | 0.4133# |
| CD39− Treg, mean ± SD (%) | 66.61 ± 3.17 | 71.38 ± 3.48 | 56.69 ± 5.81 | 0.0278 |
| CD39− Treg, median ± IQR (/μL) | 5.40 ± 7.56 | 6.43 ± 9.44 | 3.09 ± 5.12 | 0.1130# |
| CD45RA+ Treg, median ± IQR (%) | 13.98 ± 15.33 | 11.63 ± 8.09 | 27.27 ± 16.14 | 0.0028# |
| CD45RA+ Treg, median ± IQR (/μL) | 1.33 ± 1.42 | 1.17 ± 1.13 | 1.50 ± 1.70 | 0.2094# |
| CD45RA− Treg, median ± IQR (%) | 85.37 ± 15.35 | 88.37 ± 8.16 | 72.73 ± 15.81 | 0.0018# |
| CD45RA− Treg, median ± IQR (/μL) | 5.55 ± 10.63 | 5.55 ± 10.93 | 5.33 ± 5.42 | 0.2639# |
#Tested by the Mann-Whitney U test; others were tested by the unpaired t-test; SD: standard deviation; IQR: interquartile range.